Today: 20 May 2026
Browse Category

NYSE:TM 16 June 2025 - 4 March 2026

Tesla’s EU carbon-credit pool just lost Stellantis, Toyota and Subaru for 2026, filings show

Tesla’s EU carbon-credit pool just lost Stellantis, Toyota and Subaru for 2026, filings show

Stellantis, Toyota, and Subaru have not joined Tesla’s 2026 EU carbon-credit pool, an EU filing showed, though all three participated in 2025. Stellantis said it may opt in later; Toyota called pooling decisions premature. The EU now allows carmakers to average CO2 targets over 2025–2027. Tesla’s regulatory credit revenue fell 28% to $1.99 billion in 2025.
Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

Toyota shares rose 2% to 3,780 yen Friday after the company raised its full-year profit forecast and announced CFO Kenta Kon will replace CEO Koji Sato on April 1. Third-quarter net revenues climbed 6.8% to 38.087 trillion yen, but North America posted a 5.6 billion yen operating loss. Toyota’s U.S. ADRs closed up 2.9%. The tender offer for Toyota Industries shares closes Feb. 12.
Toyota recalls 162,000 Tundra trucks in the U.S. over screen failure that can blank the backup camera

Toyota recalls 162,000 Tundra trucks in the U.S. over screen failure that can blank the backup camera

Toyota is recalling about 162,000 model year 2024-2025 Tundra and Tundra Hybrid pickups in the U.S. due to a defect that can cause the multimedia display to freeze or go black, blocking the rearview camera image. Dealers will update the software free of charge. Owners will be notified by late March. Toyota did not say if the issue has caused any crashes or injuries.
25 January 2026
Toyota stock in focus: Elliott calls Toyota Industries bid “undervalued” as a Feb. 12 deadline looms

Toyota stock in focus: Elliott calls Toyota Industries bid “undervalued” as a Feb. 12 deadline looms

Toyota Motor’s U.S. shares closed at $231.42, down 0.3% Friday, as Elliott urged investors to reject Toyota Group’s bid for Toyota Industries, calling it nearly 40% too low. The tender offer, raised last week to 18,800 yen per share, runs until February 12. Toyota acknowledged Elliott’s letter and said it is monitoring developments. U.S. markets were closed Monday for Martin Luther King Jr. Day.
19 January 2026
Toyota stock price faces Monday test as yen rallies on intervention talk, Feb. 6 results ahead

Toyota stock price faces Monday test as yen rallies on intervention talk, Feb. 6 results ahead

Toyota shares closed at 3,670 yen in Tokyo, down 1.18%, as the yen strengthened on signals of possible coordinated FX intervention with the U.S. The currency move pressured exporters and drew attention ahead of Toyota’s Feb. 6 earnings report. Investors are also watching the ongoing Toyota Industries tender offer, which runs through Feb. 12.
Toyota stock pops after electric Hilux reveal; yen and tariff risk back in focus

Toyota stock pops after electric Hilux reveal; yen and tariff risk back in focus

Toyota’s U.S.-listed shares rose 3.2% to $221.52 Friday after unveiling a new Hilux lineup in Europe, including its first battery-electric model. The Hilux BEV, shown at the Brussels Motor Show, features a 59.2 kWh battery and 160-mile range, with sales set for April 2026. Toyota’s Tokyo shares closed up 2.85%. Investors are watching currency moves and upcoming Bank of Japan policy decisions.
Toyota Motor Corporation Stock Jumps to Fresh Highs on Hybrid Momentum, U.S. Investment Push, and a Shifting EV Policy Backdrop (TM, 7203)

Toyota Motor Corporation Stock Jumps to Fresh Highs on Hybrid Momentum, U.S. Investment Push, and a Shifting EV Policy Backdrop (TM, 7203)

Toyota shares hit a 52-week high of ¥3,358 in Tokyo on December 15, closing at ¥3,350. U.S.-listed ADRs rose about $7 to $215.24. The gains follow strong hybrid sales, with hybrids making up 42% of Toyota’s global sales so far in 2025. Toyota also began production at its $13.9 billion North Carolina battery plant last month.
Car, Motorcycle and EV Stocks After the Bell on December 10, 2025: GM Hits Records, Tesla Balances AI Hype and EV ‘Winter’ Fears

Car, Motorcycle and EV Stocks After the Bell on December 10, 2025: GM Hits Records, Tesla Balances AI Hype and EV ‘Winter’ Fears

General Motors hit a record high near $78.04 on December 10, 2025, extending a year-long rally, while Toyota shares rose on activist interest. Rivian and Lucid shares remained volatile as investors weighed concerns over an “EV winter” and policy changes in Europe. Global markets traded cautiously ahead of the U.S. Federal Reserve’s rate decision. Indian and European auto stocks saw mixed moves amid broader market uncertainty.
Toyota Motor (TM) Stock Today, November 26, 2025: Dividend Payout Day as Hybrid Push Battles Tariff Hit

Toyota Motor (TM) Stock Today, November 26, 2025: Dividend Payout Day as Hybrid Push Battles Tariff Hit

Toyota shares rose 1.7% in Tokyo to ¥3,128 after the company paid a higher semi-annual dividend of ¥45 per share for Q2 FY2026, up from ¥40 last year. New York ADRs traded at $200.26, up 0.65%. The dividend payment, hitting investor accounts today, lifted the forward yield to just over 3%. Toyota also released fresh FY2026 semi-annual filings.
Toyota Doubles Down on Hybrids in 2025 With $912M U.S. Bet and Dealer‑First Strategy

Toyota Doubles Down on Hybrids in 2025 With $912M U.S. Bet and Dealer‑First Strategy

Toyota announced a $912 million investment on Nov. 19, 2025, to expand hybrid production at five U.S. plants, creating 252 jobs. The largest share, $453 million, will go to its West Virginia facility. Toyota now holds over 51% of the U.S. hybrid market. Separately, over 10,000 Urban Cruiser Hyryder SUVs were recalled in India for a fuel-level indicator issue.
19 November 2025
Tesla’s ‘Affordable’ EV Gamble Backfires – Stock Sinks as Cheaper Models Disappoint Investors

Car Stocks Whipsaw on Earnings Surprises and EV Jitters – Oct. 29 Update

Tesla shares fell 4% after Q3 profit missed estimates despite record deliveries, trading near $460. Ford jumped 5% on strong earnings, while GM surged 15% after raising its profit outlook. BYD reported its first sales drop in five years and cut its 2025 target. Rivian is cutting 600 jobs and lowered its delivery forecast as EV demand slows.
Blockchain Boom: 11 Shocking Crypto Developments (Sept 3–4, 2025)

Blockchain Boom: 11 Shocking Crypto Developments (Sept 3–4, 2025)

Bitcoin hovered near $112,000 and Ethereum topped $4,400 in early September, with MemeCore up 35% and OKB rising 8.5%. Trimont LLC piloted JPMorgan’s Kinexys blockchain, while Toyota partnered with Avalanche for a Mobility Network. Galaxy Digital moved to tokenize its Nasdaq shares on Solana. Solana’s “Alpenglow” upgrade passed with 98% approval, slashing transaction finality to 0.15 seconds.
Record Closing Highs, GPT-5 Unleashed, and a $500 Billion Surprise – Business News Roundup (Aug 9–10, 2025)

Record Closing Highs, GPT-5 Unleashed, and a $500 Billion Surprise – Business News Roundup (Aug 9–10, 2025)

The Nasdaq Composite closed at its 18th record high of 2025. OpenAI launched GPT-5 for 700 million users, targeting a $500 billion valuation. Federal Reserve Vice Chair Michelle Bowman signaled three rate cuts likely by year-end. Nexstar Media Group entered advanced talks to acquire Tegna, sending Tegna shares up 30%.
Beyond Lithium-Ion: Sodium-Ion vs. Solid-State vs. Lithium-Sulfur – Who Wins the Next Battery Race?

Beyond Lithium-Ion: Sodium-Ion vs. Solid-State vs. Lithium-Sulfur – Who Wins the Next Battery Race?

CATL began deploying the world’s first mass-produced sodium-ion EV battery, Naxtra, in late 2023, with pack costs at $77/kWh and a target of $40/kWh after scaling. CATL’s sodium-ion cells deliver up to 175 Wh/kg, with a second-generation cell expected to exceed 200 Wh/kg. Toyota projects its solid-state lithium packs, due in 2027–28, will boost range by 20%. LG Energy Solution plans to mass-produce lithium-sulfur batteries by 2027.
EV Battery Economics 2025: Cost-Parity Milestones and Chemistry Breakthroughs

EV Battery Economics 2025: Cost-Parity Milestones and Chemistry Breakthroughs

Global EV battery pack prices dropped about 20% in 2024, reaching the low $100s per kWh. LFP cells in China fell below $60/kWh, with some packs under $90/kWh. As of 2025, LFP makes up 40–45% of global EV battery capacity, NMC about 50–55%, and China holds over 70% of global cell capacity. U.S. battery tax credits and new European factories are spurring investment and local production.
Top 10 Tech Trends Exploding in 2025: Generative AI, Quantum Leaps, Biotech Breakthroughs & More

Top 10 Tech Trends Exploding in 2025: Generative AI, Quantum Leaps, Biotech Breakthroughs & More

Enterprise adoption of generative AI doubled to 65% in 2025, with 92% of Fortune 500 companies using OpenAI technology. IBM unveiled a 200-logical-qubit quantum machine, Starling, for 2029. Global cybersecurity spending is set to top $200 billion in 2025. About 1 billion wearable devices are in use worldwide by mid-2025.
Beyond Lithium-Ion: How Solid-State, Lithium-Sulfur, Sodium-Ion & Graphene Batteries Will Revolutionize EVs, Gadgets and Grid Storage

Beyond Lithium-Ion: How Solid-State, Lithium-Sulfur, Sodium-Ion & Graphene Batteries Will Revolutionize EVs, Gadgets and Grid Storage

Toyota targets solid-state EV batteries with 750-mile range and 10-minute charging by 2027–2028. CATL claims 175 Wh/kg sodium-ion cells with 10,000+ cycles; Chery launched the first Na-ion EV in 2023. Flow batteries see 700 MWh deployment in China. Lyten and Samsung SDI advance graphene and solid-state prototypes, while automakers test Li‑S and niobium‑graphene cells for longer life and faster charging.

Stock Market Today

  • Roivant Sciences Q4 Loss Beats Estimates; Revenue Misses
    May 20, 2026, 9:59 AM EDT. Roivant Sciences Ltd. reported a fourth-quarter loss of $0.23 per share, better than the Zacks estimate of a $0.25 loss, marking an 8% positive earnings surprise. Revenue missed expectations, coming in at $28.93 million, down 11% from estimates but up from $27.38 million a year ago. Despite three out of four quarters beating EPS estimates recently, the company's shares have declined 4.5% year-to-date, underperforming the S&P 500's 10.4% rise. Earnings outlook remains cautious with a Zacks Rank #4 (Sell), suggesting expected near-term underperformance. Current consensus projects a loss of $0.21 per share next quarter on $56.64 million revenue and a fiscal year loss of $1.07 on $172.45 million. Industry outlook in medical-biomedical genetics also weighs on investor sentiment.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
Go toTop